6.
Meur G, Simon A, Harun N, Virally M, Dechaume A, Bonnefond A
. Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention. Diabetes. 2009; 59(3):653-61.
PMC: 2828668.
DOI: 10.2337/db09-1091.
View
7.
Karamyshev A, Patrick A, Karamysheva Z, Griesemer D, Hudson H, Tjon-Kon-Sang S
. Inefficient SRP interaction with a nascent chain triggers a mRNA quality control pathway. Cell. 2014; 156(1-2):146-57.
PMC: 3931426.
DOI: 10.1016/j.cell.2013.12.017.
View
8.
Nesmeyanova M, Karamyshev A, Karamysheva Z, Kalinin A, Ksenzenko V, Kajava A
. Positively charged lysine at the N-terminus of the signal peptide of the Escherichia coli alkaline phosphatase provides the secretion efficiency and is involved in the interaction with anionic phospholipids. FEBS Lett. 1997; 403(2):203-7.
DOI: 10.1016/s0014-5793(97)00052-5.
View
9.
Park S, Ye H, Steiner D, Bell G
. Mutant proinsulin proteins associated with neonatal diabetes are retained in the endoplasmic reticulum and not efficiently secreted. Biochem Biophys Res Commun. 2009; 391(3):1449-54.
PMC: 2817945.
DOI: 10.1016/j.bbrc.2009.12.090.
View
10.
Karamysheva Z, Karamyshev A
. Aberrant protein targeting activates quality control on the ribosome. Front Cell Dev Biol. 2023; 11:1198184.
PMC: 10279951.
DOI: 10.3389/fcell.2023.1198184.
View
11.
Guo H, Sun J, Li X, Xiong Y, Wang H, Shu H
. Positive charge in the n-region of the signal peptide contributes to efficient post-translational translocation of small secretory preproteins. J Biol Chem. 2017; 293(6):1899-1907.
PMC: 5808753.
DOI: 10.1074/jbc.RA117.000922.
View
12.
Liu M, Sun J, Cui J, Chen W, Guo H, Barbetti F
. INS-gene mutations: from genetics and beta cell biology to clinical disease. Mol Aspects Med. 2014; 42:3-18.
PMC: 4404187.
DOI: 10.1016/j.mam.2014.12.001.
View
13.
Liaci A, Steigenberger B, de Souza P, Tamara S, Grollers-Mulderij M, Ogrissek P
. Structure of the human signal peptidase complex reveals the determinants for signal peptide cleavage. Mol Cell. 2021; 81(19):3934-3948.e11.
DOI: 10.1016/j.molcel.2021.07.031.
View
14.
Tikhonova E, Karamysheva Z, von Heijne G, Karamyshev A
. Silencing of Aberrant Secretory Protein Expression by Disease-Associated Mutations. J Mol Biol. 2019; 431(14):2567-2580.
PMC: 6684239.
DOI: 10.1016/j.jmb.2019.05.011.
View
15.
Stoy J, De Franco E, Ye H, Park S, Bell G, Hattersley A
. In celebration of a century with insulin - Update of insulin gene mutations in diabetes. Mol Metab. 2021; 52:101280.
PMC: 8513141.
DOI: 10.1016/j.molmet.2021.101280.
View
16.
Karamyshev A, Tikhonova E, Karamysheva Z
. Translational Control of Secretory Proteins in Health and Disease. Int J Mol Sci. 2020; 21(7).
PMC: 7177344.
DOI: 10.3390/ijms21072538.
View
17.
Guarnizo S, Kellogg M, Miller S, Tikhonova E, Karamysheva Z, Karamyshev A
. Pathogenic signal peptide variants in the human genome. NAR Genom Bioinform. 2023; 5(4):lqad093.
PMC: 10583284.
DOI: 10.1093/nargab/lqad093.
View
18.
Cui J, Chen W, Sun J, Guo H, Madley R, Xiong Y
. Competitive Inhibition of the Endoplasmic Reticulum Signal Peptidase by Non-cleavable Mutant Preprotein Cargos. J Biol Chem. 2015; 290(47):28131-28140.
PMC: 4653672.
DOI: 10.1074/jbc.M115.692350.
View
19.
Liu M, Huang Y, Xu X, Li X, Alam M, Arunagiri A
. Normal and defective pathways in biogenesis and maintenance of the insulin storage pool. J Clin Invest. 2021; 131(2).
PMC: 7810482.
DOI: 10.1172/JCI142240.
View
20.
Schmittgen T, Livak K
. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6):1101-8.
DOI: 10.1038/nprot.2008.73.
View